HBK Investments’s Precigen PGEN Stock Holding History

HBK Investments’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,200	Closed	-$91K	–	924
2021 Q1	$91K	Hold	13,200	–	–	﹤0.01%	755
2020 Q4	$135K	Sell	13,200 -204,300	-94%	-$1.32M	﹤0.01%	665
2020 Q3	$761K	Sell	217,500 -412,500	-65%	-$1.96M	0.01%	477
2020 Q2	$3.14M	Buy	+630,000	New	+$2.14M	0.04%	246
2020 Q1	–	Sell	-722,400	Closed	-$3.96M	–	398
2019 Q4	$3.96M	Hold	722,400	–	–	0.04%	326
2019 Q3	$4.13M	Hold	722,400	–	–	0.05%	301
2019 Q2	$5.53M	Sell	722,400 -15,100	-2%	-$81.3K	0.05%	210
2019 Q1	$3.88M	Buy	737,500 +174,900	+31%	+$1.21M	0.04%	381
2018 Q4	$3.68M	Buy	562,600 +118,800	+27%	+$1.33M	0.04%	352
2018 Q3	$7.64M	Buy	+443,800	New	+$6.6M	0.06%	195

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's PGEN Position: Q2 2021 in Review

HBK Investments sold out of Precigen (PGEN) in Q2 2021, closing a stake of 220,692 shares — an estimated $1.52M sold.

HBK Investments first reported a position in PGEN in Q2 2018 and held it in 6 quarters. The position peaked at $1.52M in Q1 2021. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

HBK Investments reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
HBK Investments sold 220,692 Precigen shares in Q2 2021, an estimated $1.52M.
HBK Investments first reported a position in Precigen in Q2 2018 and held it in 6 quarters.
HBK Investments's Precigen position peaked at $1.52M in Q1 2021.
150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.